ID   STING_RAT               Reviewed;         379 AA.
AC   F1M391;
DT   05-OCT-2016, integrated into UniProtKB/Swiss-Prot.
DT   03-APR-2013, sequence version 2.
DT   02-OCT-2024, entry version 90.
DE   RecName: Full=Stimulator of interferon genes protein {ECO:0000303|PubMed:26669264};
DE            Short=rSTING {ECO:0000303|PubMed:26669264};
DE   AltName: Full=Transmembrane protein 173 {ECO:0000305};
GN   Name=Sting1 {ECO:0000250|UniProtKB:Q86WV6};
GN   Synonyms=Sting {ECO:0000303|PubMed:26669264},
GN   Tmem173 {ECO:0000312|RGD:1562552};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Brown Norway;
RX   PubMed=15057822; DOI=10.1038/nature02426;
RA   Gibbs R.A., Weinstock G.M., Metzker M.L., Muzny D.M., Sodergren E.J.,
RA   Scherer S., Scott G., Steffen D., Worley K.C., Burch P.E., Okwuonu G.,
RA   Hines S., Lewis L., Deramo C., Delgado O., Dugan-Rocha S., Miner G.,
RA   Morgan M., Hawes A., Gill R., Holt R.A., Adams M.D., Amanatides P.G.,
RA   Baden-Tillson H., Barnstead M., Chin S., Evans C.A., Ferriera S.,
RA   Fosler C., Glodek A., Gu Z., Jennings D., Kraft C.L., Nguyen T.,
RA   Pfannkoch C.M., Sitter C., Sutton G.G., Venter J.C., Woodage T., Smith D.,
RA   Lee H.-M., Gustafson E., Cahill P., Kana A., Doucette-Stamm L.,
RA   Weinstock K., Fechtel K., Weiss R.B., Dunn D.M., Green E.D.,
RA   Blakesley R.W., Bouffard G.G., De Jong P.J., Osoegawa K., Zhu B., Marra M.,
RA   Schein J., Bosdet I., Fjell C., Jones S., Krzywinski M., Mathewson C.,
RA   Siddiqui A., Wye N., McPherson J., Zhao S., Fraser C.M., Shetty J.,
RA   Shatsman S., Geer K., Chen Y., Abramzon S., Nierman W.C., Havlak P.H.,
RA   Chen R., Durbin K.J., Egan A., Ren Y., Song X.-Z., Li B., Liu Y., Qin X.,
RA   Cawley S., Cooney A.J., D'Souza L.M., Martin K., Wu J.Q.,
RA   Gonzalez-Garay M.L., Jackson A.R., Kalafus K.J., McLeod M.P.,
RA   Milosavljevic A., Virk D., Volkov A., Wheeler D.A., Zhang Z., Bailey J.A.,
RA   Eichler E.E., Tuzun E., Birney E., Mongin E., Ureta-Vidal A., Woodwark C.,
RA   Zdobnov E., Bork P., Suyama M., Torrents D., Alexandersson M., Trask B.J.,
RA   Young J.M., Huang H., Wang H., Xing H., Daniels S., Gietzen D., Schmidt J.,
RA   Stevens K., Vitt U., Wingrove J., Camara F., Mar Alba M., Abril J.F.,
RA   Guigo R., Smit A., Dubchak I., Rubin E.M., Couronne O., Poliakov A.,
RA   Huebner N., Ganten D., Goesele C., Hummel O., Kreitler T., Lee Y.-A.,
RA   Monti J., Schulz H., Zimdahl H., Himmelbauer H., Lehrach H., Jacob H.J.,
RA   Bromberg S., Gullings-Handley J., Jensen-Seaman M.I., Kwitek A.E.,
RA   Lazar J., Pasko D., Tonellato P.J., Twigger S., Ponting C.P., Duarte J.M.,
RA   Rice S., Goodstadt L., Beatson S.A., Emes R.D., Winter E.E., Webber C.,
RA   Brandt P., Nyakatura G., Adetobi M., Chiaromonte F., Elnitski L.,
RA   Eswara P., Hardison R.C., Hou M., Kolbe D., Makova K., Miller W.,
RA   Nekrutenko A., Riemer C., Schwartz S., Taylor J., Yang S., Zhang Y.,
RA   Lindpaintner K., Andrews T.D., Caccamo M., Clamp M., Clarke L., Curwen V.,
RA   Durbin R.M., Eyras E., Searle S.M., Cooper G.M., Batzoglou S., Brudno M.,
RA   Sidow A., Stone E.A., Payseur B.A., Bourque G., Lopez-Otin C., Puente X.S.,
RA   Chakrabarti K., Chatterji S., Dewey C., Pachter L., Bray N., Yap V.B.,
RA   Caspi A., Tesler G., Pevzner P.A., Haussler D., Roskin K.M., Baertsch R.,
RA   Clawson H., Furey T.S., Hinrichs A.S., Karolchik D., Kent W.J.,
RA   Rosenbloom K.R., Trumbower H., Weirauch M., Cooper D.N., Stenson P.D.,
RA   Ma B., Brent M., Arumugam M., Shteynberg D., Copley R.R., Taylor M.S.,
RA   Riethman H., Mudunuri U., Peterson J., Guyer M., Felsenfeld A., Old S.,
RA   Mockrin S., Collins F.S.;
RT   "Genome sequence of the Brown Norway rat yields insights into mammalian
RT   evolution.";
RL   Nature 428:493-521(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Brown Norway;
RA   Mural R.J., Adams M.D., Myers E.W., Smith H.O., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   FUNCTION, X-RAY CRYSTALLOGRAPHY (1.55 ANGSTROMS) OF 140-337 OF APOPROTEIN
RP   AND IN COMPLEX WITH 2'-3' LINKED CGAMP, SUBUNIT, MUTAGENESIS OF PRO-141;
RP   GLU-143; VAL-144; SER-145; GLU-149; GLU-150; LYS-151 AND THR-230, AND
RP   ACTIVITY REGULATION.
RX   PubMed=26669264; DOI=10.1038/srep18035;
RA   Zhang H., Han M.J., Tao J., Ye Z.Y., Du X.X., Deng M.J., Zhang X.Y.,
RA   Li L.F., Jiang Z.F., Su X.D.;
RT   "Rat and human STINGs profile similarly towards anticancer/antiviral
RT   compounds.";
RL   Sci. Rep. 5:18035-18035(2015).
CC   -!- FUNCTION: Facilitator of innate immune signaling that acts as a sensor
CC       of cytosolic DNA from bacteria and viruses and promotes the production
CC       of type I interferon (IFN-alpha and IFN-beta) (PubMed:26669264). Innate
CC       immune response is triggered in response to non-CpG double-stranded DNA
CC       from viruses and bacteria delivered to the cytoplasm (By similarity).
CC       Acts by binding cyclic dinucleotides: recognizes and binds cyclic di-
CC       GMP (c-di-GMP), a second messenger produced by bacteria, cyclic UMP-AMP
CC       (2',3'-cUAMP), and cyclic GMP-AMP (cGAMP), a messenger produced by CGAS
CC       in response to DNA virus in the cytosol (By similarity). Upon binding
CC       to c-di-GMP, cUAMP or cGAMP, STING1 oligomerizes, translocates from the
CC       endoplasmic reticulum and is phosphorylated by TBK1 on the pLxIS motif,
CC       leading to recruitment and subsequent activation of the transcription
CC       factor IRF3 to induce expression of type I interferon and exert a
CC       potent anti-viral state (PubMed:26669264). Exhibits 2',3'
CC       phosphodiester linkage-specific ligand recognition: can bind both 2'-3'
CC       linked cGAMP (2'-3'-cGAMP) and 3'-3' linked cGAMP but is preferentially
CC       activated by 2'-3' linked cGAMP (PubMed:26669264). The preference for
CC       2'-3'-cGAMP, compared to other linkage isomers is probably due to the
CC       ligand itself, whichs adopts an organized free-ligand conformation that
CC       resembles the STING1-bound conformation and pays low energy costs in
CC       changing into the active conformation (By similarity). In addition to
CC       promote the production of type I interferons, plays a direct role in
CC       autophagy (By similarity). Following cGAMP-binding, STING1 buds from
CC       the endoplasmic reticulum into COPII vesicles, which then form the
CC       endoplasmic reticulum-Golgi intermediate compartment (ERGIC) (By
CC       similarity). The ERGIC serves as the membrane source for WIPI2
CC       recruitment and LC3 lipidation, leading to formation of autophagosomes
CC       that target cytosolic DNA or DNA viruses for degradation by the
CC       lysosome (By similarity). Promotes autophagy by acting as a proton
CC       channel that directs proton efflux from the Golgi to facilitate
CC       MAP1LC3B/LC3B lipidation (By similarity). The autophagy- and
CC       interferon-inducing activities can be uncoupled and autophagy induction
CC       is independent of TBK1 phosphorylation (By similarity). Autophagy is
CC       also triggered upon infection by bacteria: following c-di-GMP-binding,
CC       which is produced by live Gram-positive bacteria, promotes
CC       reticulophagy (By similarity). May be involved in translocon function,
CC       the translocon possibly being able to influence the induction of type I
CC       interferons (By similarity). May be involved in transduction of
CC       apoptotic signals via its association with the major histocompatibility
CC       complex class II (MHC-II) (By similarity).
CC       {ECO:0000250|UniProtKB:Q3TBT3, ECO:0000250|UniProtKB:Q86WV6,
CC       ECO:0000269|PubMed:26669264}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H(+)(in) = H(+)(out); Xref=Rhea:RHEA:34979, ChEBI:CHEBI:15378;
CC         Evidence={ECO:0000250|UniProtKB:Q86WV6};
CC   -!- ACTIVITY REGULATION: In contrast to mouse protein, not activated by
CC       anticancer molecule 5,6-dimethylxanthenone 4-acetic acid (DMXAA).
CC       {ECO:0000269|PubMed:26669264}.
CC   -!- SUBUNIT: Homodimer; forms a homodimer in absence of cyclic nucleotide
CC       (c-di-GMP or cGAMP); 'Lys-63'-linked ubiquitination at Lys-151 is
CC       required for homodimerization (PubMed:26669264). Homotetramer; in
CC       presence of cyclic nucleotide (c-di-GMP or cGAMP), forms tetramers and
CC       higher-order oligomers through side-by-side packing (By similarity).
CC       Interacts (when phosphorylated) with IRF3; following activation and
CC       phosphorylation on the pLxIS motif by TBK1, recruits IRF3 (By
CC       similarity). Interacts with RIGI, MAVS and SSR2 (By similarity).
CC       Interacts with RNF5 and TRIM56 (By similarity). Interacts with TBK1;
CC       when homodimer, leading to subsequent production of IFN-beta (By
CC       similarity). Interacts with IFIT1 and IFIT2 (By similarity). Interacts
CC       with TRIM29; this interaction induces STING1 ubiquitination and
CC       subsequent degradation (By similarity). Associates with the MHC-II
CC       complex (By similarity). Interacts with STEEP1; interaction takes place
CC       upon cGAMP-activation and STING1 phosphorylation by MAP3K7/TAK1 and
CC       promotes STING1 translocation to COPII vesicles (By similarity).
CC       Interacts with SEC24A, SEC24B and SEC24C; promoting translocation to
CC       COPII vesicles (By similarity). Interacts (when ubiquitinated) with
CC       SQSTM1; leading to relocalization to autophagosomes (By similarity).
CC       Interacts with SURF4 (By similarity). Interacts with HNRNPA2B1 (By
CC       similarity). Interacts with ZDHHC1; ZDHHC1 constitutively interacts
CC       with STING1 and in presence of DNA viruses activates it by promoting
CC       its cGAMP-induced oligomerization and the recruitment of downstream
CC       signaling components (By similarity). Interacts with ZDHHC11; in
CC       presence of DNA viruses promotes the recruitment of IRF3 to STING1 (By
CC       similarity). Interacts with TOMM70 (By similarity). Interacts with
CC       TAB1; promoting recruitment of TAB1 to the endoplasmic reticulum
CC       membrane and subsequent activation of MAP3K7/TAK1 (By similarity).
CC       Interacts (via transmembrane domain) with TMEM203 (By similarity).
CC       {ECO:0000250|UniProtKB:Q3TBT3, ECO:0000250|UniProtKB:Q86WV6,
CC       ECO:0000269|PubMed:26669264}.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000250|UniProtKB:Q86WV6}; Multi-pass membrane protein
CC       {ECO:0000250|UniProtKB:Q86WV6, ECO:0000255}. Cytoplasm, perinuclear
CC       region {ECO:0000250|UniProtKB:Q86WV6}. Endoplasmic reticulum-Golgi
CC       intermediate compartment membrane {ECO:0000250|UniProtKB:Q86WV6};
CC       Multi-pass membrane protein {ECO:0000255}. Golgi apparatus membrane
CC       {ECO:0000250|UniProtKB:Q86WV6}; Multi-pass membrane protein
CC       {ECO:0000255}. Cytoplasmic vesicle, autophagosome membrane
CC       {ECO:0000250|UniProtKB:Q86WV6}; Multi-pass membrane protein
CC       {ECO:0000255}. Mitochondrion outer membrane
CC       {ECO:0000250|UniProtKB:Q86WV6}; Multi-pass membrane protein
CC       {ECO:0000255}. Cell membrane {ECO:0000250|UniProtKB:Q3TBT3}; Multi-pass
CC       membrane protein {ECO:0000255}. Note=In response to double-stranded DNA
CC       stimulation, translocates from the endoplasmic reticulum through the
CC       endoplasmic reticulum-Golgi intermediate compartment and Golgi to post-
CC       Golgi vesicles, where the kinase TBK1 is recruited. Upon cGAMP-binding,
CC       translocates to the endoplasmic reticulum-Golgi intermediate
CC       compartment (ERGIC) in a process that is dependent on COPII vesicles;
CC       STING1-containing ERGIC serves as a membrane source for LC3 lipidation,
CC       which is a key step in autophagosome biogenesis. Localizes in the
CC       lysosome membrane in a TMEM203-dependent manner.
CC       {ECO:0000250|UniProtKB:Q3TBT3, ECO:0000250|UniProtKB:Q86WV6}.
CC   -!- DOMAIN: In absence of cGAMP, the transmembrane and cytoplasmic regions
CC       interact to form an integrated, domain-swapped dimeric assembly (By
CC       similarity). In absence of cyclic nucleotide (c-di-GMP or cGAMP), the
CC       protein is autoinhibited by an intramolecular interaction between the
CC       cyclic dinucleotide-binding domain (CBD) and the C-terminal tail (CTT)
CC       (By similarity). Following cGAMP-binding, the cyclic dinucleotide-
CC       binding domain (CBD) is closed, leading to a 180 degrees rotation of
CC       the CBD domain relative to the transmembrane domain. This rotation is
CC       coupled to a conformational change in a loop on the side of the CBD
CC       dimer, which leads to the formation of the STING1 tetramer and higher-
CC       order oligomers through side-by-side packing (By similarity). The N-
CC       terminal part of the CBD region was initially though to contain a fifth
CC       transmembrane region (TM5) but is part of the folded, soluble CBD (By
CC       similarity). {ECO:0000250|UniProtKB:E1C7U0,
CC       ECO:0000250|UniProtKB:Q86WV6}.
CC   -!- DOMAIN: The pLxIS motif constitutes an IRF3-binding motif: following
CC       phosphorylation by TBK1, the phosphorylated pLxIS motif of STING1
CC       recruits IRF3. IRF3 is then phosphorylated and activated by TBK1 to
CC       induce type-I interferons and other cytokines.
CC       {ECO:0000250|UniProtKB:Q86WV6}.
CC   -!- DOMAIN: The N-terminal domain interacts with glycerophospholipids and
CC       phospholipids. {ECO:0000250|UniProtKB:Q86WV6}.
CC   -!- PTM: Phosphorylation by TBK1 leads to activation and production of IFN-
CC       beta. Following cyclic nucleotide (c-di-GMP or cGAMP)-binding,
CC       activation and translocation from the endoplasmic reticulum, STING1 is
CC       phosphorylated by TBK1 at Ser-366 in the pLxIS motif. The
CC       phosphorylated pLxIS motif constitutes an IRF3-binding motif, leading
CC       to recruitment of the transcription factor IRF3 to induce type-I
CC       interferons and other cytokines (By similarity). Phosphorylated on
CC       tyrosine residues upon MHC-II aggregation (By similarity).
CC       Dephosphorylation by PPP6C leads to inactivation and decreased
CC       production of IFN-beta (By similarity). Phosphorylation at Ser-358 is
CC       also required to activate IRF3 (By similarity). Phosphorylation at Ser-
CC       355 by MAP3K7/TAK1 facilitates its interaction with STEEP1, promoting
CC       STING1 translocation to COPII vesicles (By similarity).
CC       {ECO:0000250|UniProtKB:Q3TBT3, ECO:0000250|UniProtKB:Q86WV6}.
CC   -!- PTM: Ubiquitinated (By similarity). Ubiquitinated via 'Lys-63'-linked
CC       ubiquitin chains in response to double-stranded DNA treatment, leading
CC       to relocalization to autophagosomes and subsequent degradation; this
CC       process is dependent on SQSTM1 (By similarity). 'Lys-63'-linked
CC       ubiquitination mediated by TRIM56 at Lys-151 promotes homodimerization
CC       and recruitment of the antiviral kinase TBK1 and subsequent production
CC       of IFN-beta. 'Lys-48'-linked polyubiquitination at Lys-151 occurring
CC       after viral infection is mediated by RNF5 and leads to proteasomal
CC       degradation. 'Lys-11'-linked polyubiquitination at Lys-151 by RNF26
CC       leads to stabilize STING1: it protects STING1 from RNF5-mediated 'Lys-
CC       48'-linked polyubiquitination (By similarity). 'Lys-33'-linked and
CC       'Lys-48'-linked deubiquitinated by USP20; leading to its stabilization
CC       and promotion of innate antiviral response (By similarity). 'Lys-48'-
CC       linked deubiquitinated by USP44; leading to its stabilization and
CC       promotion of innate antiviral response (By similarity). Deubiquitinated
CC       by USP13; leading to inhibition of innate antiviral response (By
CC       similarity). 'Lys-63'-linked deubiquitinated by USP49; leading to
CC       inhibition of the subsequent recruitment of TBK1 to the signaling
CC       complex (By similarity). {ECO:0000250|UniProtKB:Q3TBT3,
CC       ECO:0000250|UniProtKB:Q86WV6}.
CC   -!- PTM: Sumoylated at Lys-338 by TRIM38 during the early phase of viral
CC       infection, promoting its stability by preventing its relocalization to
CC       autophagosomes and subsequent degradation. Desumoylated by SENP2 during
CC       the late phase of viral infection. {ECO:0000250|UniProtKB:Q3TBT3}.
CC   -!- PTM: Palmitoylation takes place in the Golgi apparatus and creates a
CC       platform for the recruitment of TBK1. {ECO:0000250|UniProtKB:Q3TBT3}.
CC   -!- SIMILARITY: Belongs to the STING family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AABR07072583; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC135285; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH473974; EDL76277.1; -; Genomic_DNA.
DR   RefSeq; NP_001102592.1; NM_001109122.1.
DR   PDB; 5GRM; X-ray; 1.55 A; A/B=155-341.
DR   PDB; 5GS5; X-ray; 1.84 A; A/B/C/D=140-337.
DR   PDBsum; 5GRM; -.
DR   PDBsum; 5GS5; -.
DR   AlphaFoldDB; F1M391; -.
DR   SMR; F1M391; -.
DR   STRING; 10116.ENSRNOP00000063348; -.
DR   BindingDB; F1M391; -.
DR   ChEMBL; CHEMBL5169097; -.
DR   PhosphoSitePlus; F1M391; -.
DR   PaxDb; 10116-ENSRNOP00000063348; -.
DR   GeneID; 498840; -.
DR   KEGG; rno:498840; -.
DR   AGR; RGD:1562552; -.
DR   CTD; 340061; -.
DR   RGD; 1562552; Sting1.
DR   VEuPathDB; HostDB:ENSRNOG00000042137; -.
DR   eggNOG; ENOG502R15M; Eukaryota.
DR   HOGENOM; CLU_062449_0_0_1; -.
DR   InParanoid; F1M391; -.
DR   OrthoDB; 5352585at2759; -.
DR   TreeFam; TF324444; -.
DR   Reactome; R-RNO-1834941; STING mediated induction of host immune responses.
DR   Reactome; R-RNO-3134975; Regulation of innate immune responses to cytosolic DNA.
DR   Reactome; R-RNO-3249367; STAT6-mediated induction of chemokines.
DR   Reactome; R-RNO-3270619; IRF3-mediated induction of type I IFN.
DR   Reactome; R-RNO-6798695; Neutrophil degranulation.
DR   PRO; PR:F1M391; -.
DR   Proteomes; UP000002494; Chromosome 18.
DR   Proteomes; UP000234681; Chromosome 18.
DR   Bgee; ENSRNOG00000042137; Expressed in spleen and 20 other cell types or tissues.
DR   GO; GO:0005776; C:autophagosome; ISO:RGD.
DR   GO; GO:0000421; C:autophagosome membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR   GO; GO:0005783; C:endoplasmic reticulum; ISO:RGD.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; ISO:RGD.
DR   GO; GO:0033116; C:endoplasmic reticulum-Golgi intermediate compartment membrane; ISO:RGD.
DR   GO; GO:0005768; C:endosome; ISO:RGD.
DR   GO; GO:0005794; C:Golgi apparatus; ISO:RGD.
DR   GO; GO:0000139; C:Golgi membrane; ISO:RGD.
DR   GO; GO:0005741; C:mitochondrial outer membrane; ISO:RGD.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; ISO:RGD.
DR   GO; GO:0005777; C:peroxisome; ISO:RGD.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:1990231; C:STING complex; ISO:RGD.
DR   GO; GO:0061507; F:2',3'-cyclic GMP-AMP binding; IDA:UniProtKB.
DR   GO; GO:0035438; F:cyclic-di-GMP binding; ISO:RGD.
DR   GO; GO:0042802; F:identical protein binding; ISO:RGD.
DR   GO; GO:0042803; F:protein homodimerization activity; ISO:RGD.
DR   GO; GO:0019901; F:protein kinase binding; ISO:RGD.
DR   GO; GO:0015252; F:proton channel activity; ISS:UniProtKB.
DR   GO; GO:0061629; F:RNA polymerase II-specific DNA-binding transcription factor binding; ISO:RGD.
DR   GO; GO:0035591; F:signaling adaptor activity; ISS:UniProtKB.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; ISO:RGD.
DR   GO; GO:0002218; P:activation of innate immune response; ISO:RGD.
DR   GO; GO:0140374; P:antiviral innate immune response; ISO:RGD.
DR   GO; GO:0000045; P:autophagosome assembly; ISS:UniProtKB.
DR   GO; GO:0071360; P:cellular response to exogenous dsRNA; ISO:RGD.
DR   GO; GO:0035458; P:cellular response to interferon-beta; ISO:RGD.
DR   GO; GO:0071407; P:cellular response to organic cyclic compound; IDA:UniProtKB.
DR   GO; GO:0140896; P:cGAS/STING signaling pathway; ISS:UniProtKB.
DR   GO; GO:0002753; P:cytoplasmic pattern recognition receptor signaling pathway; ISO:RGD.
DR   GO; GO:0051607; P:defense response to virus; ISS:UniProtKB.
DR   GO; GO:0045087; P:innate immune response; ISS:UniProtKB.
DR   GO; GO:0002221; P:pattern recognition receptor signaling pathway; ISO:RGD.
DR   GO; GO:0002230; P:positive regulation of defense response to virus by host; ISO:RGD.
DR   GO; GO:0032728; P:positive regulation of interferon-beta production; ISS:UniProtKB.
DR   GO; GO:0016239; P:positive regulation of macroautophagy; ISS:UniProtKB.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0032481; P:positive regulation of type I interferon production; IDA:UniProtKB.
DR   GO; GO:0060340; P:positive regulation of type I interferon-mediated signaling pathway; ISO:RGD.
DR   GO; GO:0051259; P:protein complex oligomerization; ISO:RGD.
DR   GO; GO:0070972; P:protein localization to endoplasmic reticulum; ISO:RGD.
DR   GO; GO:0010468; P:regulation of gene expression; ISO:RGD.
DR   GO; GO:0050727; P:regulation of inflammatory response; ISO:RGD.
DR   GO; GO:0061709; P:reticulophagy; ISS:UniProtKB.
DR   CDD; cd22658; STING_C_metazoan-like; 1.
DR   Gene3D; 1.20.5.5200; -; 1.
DR   Gene3D; 3.40.50.12100; Stimulator of interferon genes protein; 1.
DR   InterPro; IPR029158; STING.
DR   InterPro; IPR047191; STING_C_chordates.
DR   InterPro; IPR038623; STING_C_sf.
DR   PANTHER; PTHR34339; STIMULATOR OF INTERFERON GENES PROTEIN; 1.
DR   PANTHER; PTHR34339:SF1; STIMULATOR OF INTERFERON GENES PROTEIN; 1.
DR   Pfam; PF15009; TMEM173; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Autophagy; Cell membrane; Cytoplasm; Cytoplasmic vesicle;
KW   Endoplasmic reticulum; Golgi apparatus; Immunity; Innate immunity;
KW   Ion channel; Ion transport; Isopeptide bond; Lipoprotein; Membrane;
KW   Mitochondrion; Mitochondrion outer membrane; Nucleotide-binding; Palmitate;
KW   Phosphoprotein; Reference proteome; Transmembrane; Transmembrane helix;
KW   Transport; Ubl conjugation.
FT   CHAIN           1..379
FT                   /note="Stimulator of interferon genes protein"
FT                   /id="PRO_0000437256"
FT   TOPO_DOM        1..17
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        18..34
FT                   /note="Helical; Name=1"
FT                   /evidence="ECO:0000250|UniProtKB:Q86WV6"
FT   TOPO_DOM        35..44
FT                   /note="Lumenal"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        45..69
FT                   /note="Helical; Name=2"
FT                   /evidence="ECO:0000250|UniProtKB:Q86WV6"
FT   TOPO_DOM        70..91
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        92..106
FT                   /note="Helical; Name=3"
FT                   /evidence="ECO:0000250|UniProtKB:Q86WV6"
FT   TOPO_DOM        107..116
FT                   /note="Lumenal"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        117..134
FT                   /note="Helical; Name=4"
FT                   /evidence="ECO:0000250|UniProtKB:Q86WV6"
FT   TOPO_DOM        135..379
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   REGION          1..190
FT                   /note="Mediates interaction with ZDHHC1 and ZDHHC11"
FT                   /evidence="ECO:0000250|UniProtKB:Q86WV6"
FT   REGION          153..340
FT                   /note="Cyclic dinucleotide-binding domain (CBD)"
FT                   /evidence="ECO:0000269|PubMed:26669264"
FT   REGION          340..379
FT                   /note="C-terminal tail (CTT)"
FT                   /evidence="ECO:0000250|UniProtKB:Q86WV6"
FT   MOTIF           363..366
FT                   /note="pLxIS motif"
FT                   /evidence="ECO:0000250|UniProtKB:Q86WV6"
FT   BINDING         162..167
FT                   /ligand="2',3'-cGAMP"
FT                   /ligand_id="ChEBI:CHEBI:143093"
FT                   /evidence="ECO:0000305|PubMed:26669264"
FT   BINDING         166
FT                   /ligand="3',3'-c-di-GMP"
FT                   /ligand_id="ChEBI:CHEBI:58805"
FT                   /evidence="ECO:0000250|UniProtKB:Q3TBT3"
FT   BINDING         167
FT                   /ligand="2',3'-cUAMP"
FT                   /ligand_id="ChEBI:CHEBI:228269"
FT                   /evidence="ECO:0000250|UniProtKB:Q86WV6"
FT   BINDING         238..241
FT                   /ligand="2',3'-cGAMP"
FT                   /ligand_id="ChEBI:CHEBI:143093"
FT                   /evidence="ECO:0000305|PubMed:26669264"
FT   BINDING         238..241
FT                   /ligand="3',3'-c-di-GMP"
FT                   /ligand_id="ChEBI:CHEBI:58805"
FT                   /evidence="ECO:0000250|UniProtKB:Q3TBT3"
FT   BINDING         238
FT                   /ligand="2',3'-cUAMP"
FT                   /ligand_id="ChEBI:CHEBI:228269"
FT                   /evidence="ECO:0000250|UniProtKB:Q86WV6"
FT   BINDING         263
FT                   /ligand="2',3'-cGAMP"
FT                   /ligand_id="ChEBI:CHEBI:143093"
FT                   /evidence="ECO:0000305|PubMed:26669264"
FT   BINDING         263
FT                   /ligand="2',3'-cUAMP"
FT                   /ligand_id="ChEBI:CHEBI:228269"
FT                   /evidence="ECO:0000250|UniProtKB:Q86WV6"
FT   BINDING         263
FT                   /ligand="3',3'-c-di-GMP"
FT                   /ligand_id="ChEBI:CHEBI:58805"
FT                   /evidence="ECO:0000250|UniProtKB:Q3TBT3"
FT   MOD_RES         241
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q86WV6"
FT   MOD_RES         355
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q86WV6"
FT   MOD_RES         358
FT                   /note="Phosphoserine; by TBK1"
FT                   /evidence="ECO:0000250|UniProtKB:Q86WV6"
FT   MOD_RES         366
FT                   /note="Phosphoserine; by TBK1"
FT                   /evidence="ECO:0000250|UniProtKB:Q86WV6"
FT   LIPID           88
FT                   /note="S-palmitoyl cysteine"
FT                   /evidence="ECO:0000250|UniProtKB:Q3TBT3"
FT   CROSSLNK        151
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000250|UniProtKB:Q3TBT3"
FT   CROSSLNK        236
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000250|UniProtKB:Q86WV6"
FT   CROSSLNK        338
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO)"
FT                   /evidence="ECO:0000250|UniProtKB:Q3TBT3"
FT   MUTAGEN         141
FT                   /note="P->A: Abolishes response to 2'-3' linked cGAMP and
FT                   3'-3' linked cGAMP and production of interferon IFNB1."
FT                   /evidence="ECO:0000269|PubMed:26669264"
FT   MUTAGEN         143
FT                   /note="E->A: Abolishes response to 2'-3' linked cGAMP and
FT                   3'-3' linked cGAMP and production of interferon IFNB1."
FT                   /evidence="ECO:0000269|PubMed:26669264"
FT   MUTAGEN         144
FT                   /note="V->A: Decreases response to 2'-3' linked cGAMP and
FT                   3'-3' linked cGAMP and production of interferon IFNB1."
FT                   /evidence="ECO:0000269|PubMed:26669264"
FT   MUTAGEN         145
FT                   /note="S->A: Abolishes response to 2'-3' linked cGAMP and
FT                   3'-3' linked cGAMP and production of interferon IFNB1."
FT                   /evidence="ECO:0000269|PubMed:26669264"
FT   MUTAGEN         149
FT                   /note="E->A,R: Abolishes response to 2'-3' linked cGAMP and
FT                   3'-3' linked cGAMP and production of interferon IFNB1."
FT                   /evidence="ECO:0000269|PubMed:26669264"
FT   MUTAGEN         150
FT                   /note="E->A: Abolishes response to 2'-3' linked cGAMP and
FT                   3'-3' linked cGAMP and production of interferon IFNB1."
FT                   /evidence="ECO:0000269|PubMed:26669264"
FT   MUTAGEN         151
FT                   /note="K->R: Abolishes response to 2'-3' linked cGAMP and
FT                   3'-3' linked cGAMP and production of interferon IFNB1."
FT                   /evidence="ECO:0000269|PubMed:26669264"
FT   MUTAGEN         230
FT                   /note="T->I,L,M,V: No effect on response to 2'-3' linked
FT                   cGAMP and production of interferon IFNB1. Strongly
FT                   increases affinity for the synthetic compound 5,6-
FT                   dimethylxanthenone 4-acetic acid (DMXAA)."
FT                   /evidence="ECO:0000269|PubMed:26669264"
FT   HELIX           155..165
FT                   /evidence="ECO:0007829|PDB:5GRM"
FT   HELIX           168..171
FT                   /evidence="ECO:0007829|PDB:5GRM"
FT   TURN            172..174
FT                   /evidence="ECO:0007829|PDB:5GRM"
FT   HELIX           175..185
FT                   /evidence="ECO:0007829|PDB:5GRM"
FT   TURN            186..188
FT                   /evidence="ECO:0007829|PDB:5GRM"
FT   HELIX           193..195
FT                   /evidence="ECO:0007829|PDB:5GRM"
FT   STRAND          196..203
FT                   /evidence="ECO:0007829|PDB:5GRM"
FT   HELIX           212..214
FT                   /evidence="ECO:0007829|PDB:5GRM"
FT   STRAND          219..224
FT                   /evidence="ECO:0007829|PDB:5GRM"
FT   STRAND          228..232
FT                   /evidence="ECO:0007829|PDB:5GRM"
FT   STRAND          235..240
FT                   /evidence="ECO:0007829|PDB:5GRM"
FT   STRAND          243..249
FT                   /evidence="ECO:0007829|PDB:5GRM"
FT   STRAND          252..261
FT                   /evidence="ECO:0007829|PDB:5GRM"
FT   HELIX           264..273
FT                   /evidence="ECO:0007829|PDB:5GRM"
FT   HELIX           275..277
FT                   /evidence="ECO:0007829|PDB:5GRM"
FT   HELIX           281..299
FT                   /evidence="ECO:0007829|PDB:5GRM"
FT   HELIX           304..306
FT                   /evidence="ECO:0007829|PDB:5GRM"
FT   STRAND          309..314
FT                   /evidence="ECO:0007829|PDB:5GRM"
FT   HELIX           316..318
FT                   /evidence="ECO:0007829|PDB:5GRM"
FT   HELIX           325..334
FT                   /evidence="ECO:0007829|PDB:5GRM"
FT   HELIX           336..339
FT                   /evidence="ECO:0007829|PDB:5GRM"
SQ   SEQUENCE   379 AA;  42655 MW;  69AB884C9DA209EC CRC64;
     MPYSNLHPSI PRPRSYRFKL AAFVLLVGSL MSLWMTGEPP SHTLHYLALH VASQQLGLLL
     KKLCCLAEEL CHVQSRYQGS YWKAVRACVG SPICFMALIL LSFYFYCSLE NTSDLRLAWH
     LGILVLSKSL SMTLDLQSLA PAEVSAVCEE KNFNVAHGLA WSYYIGYLKL ILPGLQARIR
     MFNQLHNNML SGAGSRRLYI LFPLDCGVPD DLSVADPNIR FRDMLPQQNT DRAGVKNRAY
     SNSVYELLEN GQPAGACILE YATPLQTLFA MSQDGKAGFS REDRLEQAKL FCRTLEEILA
     DVPESRNHCR LIVYQESEEG NSFSLSQEVL RHIRQEEKEE VTMSGPPTSV APRPSLLSQE
     PRLLISGMEQ PLPLRTDLI
//
